Eloxx Pharmaceuticals Inc (ELOX)
0.90
+0.05
(+5.88%)
USD |
OTCM |
May 03, 16:00
Eloxx Pharmaceuticals Market Cap: 2.829M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.829M |
| May 02, 2024 | 2.672M |
| May 01, 2024 | 2.766M |
| April 30, 2024 | 3.021M |
| April 29, 2024 | 2.860M |
| April 26, 2024 | 2.533M |
| April 25, 2024 | 2.468M |
| April 24, 2024 | 2.546M |
| April 23, 2024 | 2.593M |
| April 22, 2024 | 2.523M |
| April 19, 2024 | 2.518M |
| April 18, 2024 | 2.955M |
| April 17, 2024 | 3.026M |
| April 16, 2024 | 3.104M |
| April 15, 2024 | 3.081M |
| April 12, 2024 | 3.206M |
| April 11, 2024 | 3.080M |
| April 10, 2024 | 3.175M |
| April 09, 2024 | 3.269M |
| April 08, 2024 | 3.269M |
| April 05, 2024 | 3.143M |
| April 04, 2024 | 3.363M |
| April 03, 2024 | 3.426M |
| April 02, 2024 | 3.143M |
| April 01, 2024 | 3.206M |
| Date | Value |
|---|---|
| March 28, 2024 | 3.143M |
| March 27, 2024 | 2.829M |
| March 26, 2024 | 2.672M |
| March 25, 2024 | 2.829M |
| March 22, 2024 | 2.864M |
| March 21, 2024 | 2.986M |
| March 20, 2024 | 3.206M |
| March 19, 2024 | 3.018M |
| March 18, 2024 | 3.363M |
| March 15, 2024 | 3.458M |
| March 14, 2024 | 3.301M |
| March 13, 2024 | 3.175M |
| March 12, 2024 | 2.853M |
| March 11, 2024 | 2.986M |
| March 08, 2024 | 2.772M |
| March 07, 2024 | 2.704M |
| March 06, 2024 | 2.829M |
| March 05, 2024 | 2.897M |
| March 04, 2024 | 2.829M |
| March 01, 2024 | 2.796M |
| February 29, 2024 | 2.700M |
| February 28, 2024 | 2.515M |
| February 27, 2024 | 2.405M |
| February 26, 2024 | 2.735M |
| February 23, 2024 | 2.735M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.949M
Minimum
Dec 15 2023
426.88M
Maximum
May 09 2019
95.42M
Average
82.25M
Median
Mar 16 2020
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.856M |
| Palatin Technologies Inc | 34.05M |
| iBio Inc | 6.934M |
| Theriva Biologics Inc | 6.911M |
| Oragenics Inc | 4.794M |
Market Cap Related Metrics
| PS Ratio | 13.94 |
| Price | 0.90 |
| Earnings Yield | -1.01K% |